Table of Contents

    Topic review

    Yao Syndrome

    View times: 8
    Submitted by: Bruce Ren
    (This entry belongs to Entry Collection "MedlinePlus ")


    Yao syndrome (formerly called NOD2-associated autoinflammatory disease) is a disorder involving episodes of fever and abnormal inflammation affecting many parts of the body, particularly the skin, joints, and gastrointestinal system.

    1. Introduction

    Inflammation is a normal immune system response to injury and foreign invaders (such as bacteria). In people with Yao syndrome, part of the immune system called the innate immune response is turned on (activated) abnormally, which causes fevers and inflammation-related damage to tissues and organs. Based on this process, Yao syndrome is classified as an autoinflammatory disease. Autoinflammatory diseases are distinct from autoimmune diseases; these two groups of diseases involve abnormalities in different parts of the immune system.

    The episodes of fever and inflammation associated with Yao syndrome can last for several days and occur weeks to months apart. During these episodes, most affected individuals develop reddened, inflamed areas on the skin called erythematous patches or plaques. This reddening occurs most commonly on the face, chest, and back but can also affect the arms and legs. Episodes of joint pain and inflammation similar to arthritis are common, particularly in the legs, as is swelling of the ankles and feet. Inflammation also affects the gastrointestinal system, causing attacks of abdominal pain, bloating, and cramping with diarrhea in more than half of affected individuals. Dry eyes and dry mouth (described as "sicca-like" symptoms, which refers to dryness) are reported in about half of people with this disease. Other potential signs and symptoms of Yao syndrome include mouth sores, chest pain, and enlargement of various glands.

    Yao syndrome is usually diagnosed in adulthood. It is a long-lasting (chronic) disease, and episodes can recur for many years.

    2. Frequency

    Yao syndrome has an estimated prevalence of 1 in 10,000 to 1 in 100,000 people worldwide. Studies suggest that it is among the most common systemic (affecting the whole body) autoinflammatory diseases in adults. For unknown reasons, Yao syndrome appears to affect women more frequently than men.

    3. Causes

    The causes of Yao syndrome are complex. This condition likely results from a combination of genetic and environmental factors, many of which are unknown.

    Certain variations in the NOD2 gene increase the risk of developing Yao syndrome. The NOD2 protein plays several essential roles in the immune system's response to foreign invaders, including inflammatory reactions. Studies suggest that most people with Yao syndrome have at least one variation in the NOD2 gene, and some have two or more. It is unclear what effect these variations have on the amount or function of the NOD2 protein, or how they might contribute to abnormal inflammation in people with Yao syndrome. Researchers suspect that environmental factors such as infections may also play a role in triggering the disease in people with genetic variants that increase their risk.

    4. Inheritance

    Because Yao syndrome appears to be a complex disease without a single genetic cause, it does not have a straightforward pattern of inheritance. A small percentage of affected individuals have a family history of the disease. Many people who have one or more of the NOD2 gene variants associated with Yao syndrome never develop the disease.

    5. Other Names for This Condition

    • NAID
    • NOD2-associated AID
    • NOD2-associated autoinflammatory disease
    • YAOS

    The entry is from


    1. Estephan M, Yao Q, Springer J. Case of NOD2-Associated AutoinflammatoryDisease Successfully Treated With Sulfasalazine. J Clin Rheumatol. 2017Jan;23(1):58-59. doi: 10.1097/RHU.0000000000000468.
    2. Yao Q, Lacbawan F, Li J. Adult autoinflammatory disease frequency and ourdiagnostic experience in an adult autoinflammatory clinic. Semin Arthritis Rheum.2016 Apr;45(5):633-7. doi: 10.1016/j.semarthrit.2015.10.012.
    3. Yao Q, Myles J, Shen B, McDonald C. NOD2-associated autoinflammatory disease: an exploratory study of its pathogenesis. Rheumatology (Oxford). 2014May;53(5):958-60. doi: 10.1093/rheumatology/ket384.
    4. Yao Q, Shen B. A Systematic Analysis of Treatment and Outcomes ofNOD2-Associated Autoinflammatory Disease. Am J Med. 2017Mar;130(3):365.e13-365.e18. doi: 10.1016/j.amjmed.2016.09.028.
    5. Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2-associatedautoinflammatory disease: a large cohort study. Rheumatology (Oxford). 2015Oct;54(10):1904-12. doi: 10.1093/rheumatology/kev207.
    6. Yao Q, Su LC, Tomecki KJ, Zhou L, Jayakar B, Shen B. Dermatitis as acharacteristic phenotype of a new autoinflammatory disease associated with NOD2mutations. J Am Acad Dermatol. 2013 Apr;68(4):624-631. doi:10.1016/j.jaad.2012.09.025.
    7. Yao Q, Zhou L, Cusumano P, Bose N, Piliang M, Jayakar B, Su LC, Shen B. A new category of autoinflammatory disease associated with NOD2 gene mutations.Arthritis Res Ther. 2011;13(5):R148. doi: 10.1186/ar3462.